A Study of Tumor-Treating Fields (TTFields) in People With Lung Adenocarcinoma

Running, not enrolling · Phase 1

Conditions studied: Adenocarcinoma of Lung

In brief

The researchers are doing this study to find out if treatment with TTFields using the NovoTTF-200T System is safe and practical (feasible) before surgical removal (resection) of lung adenocarcinoma (ADC). The researchers will also look at how the treatment may help the body's immune system to fight cancer.

Key facts

Study ID
NCT05764954
Run by
Memorial Sloan Kettering Cancer Center
People needed
12
Starts
2023-08-04
Expected to finish
2027-08-01
Last updated by the study team
2026-05-28

Who can join

Age: 22 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.